1.Sherertz, RJ, Ely, EW, Westbrook, DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132:641–648.
2.Eggimann, P, Harbarth, S, Constantin, MN, Touveneau, S, Chevrolet, JC, Pittet, D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864–1868.
3.Nehme, AE. Nutritional support of the hospitalized patient: the team concept. JAMA 1980;243:1906–1908.
4.Soifer, NE, Borzak, S, Edlin, BR, Weinstein, RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998;158:473–477.
5.Tomford, JW, Hershey, CO. The i.v. therapy team: impact on patient care and costs of hospitalization. NITA 1985;8:387–389.
6.Davis, D, O'Brien, MA, Freemantle, N, Wolf, FM, Mazmanian, P, Taylor-Vaisey, A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999;282:867–874.
7.Conly, JM, Hill, S, Ross, J, Lertzman, J, Louie, TJ. Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Infect Control 1989;17:330–339.
8.East, SA. Planning, implementation, and evaluation of a successful hospital-based peripherally inserted central catheter program. Journal of Intravenous Nursing 1994;17:189–192.
9.Kyle, KS, Myers, JS. Peripherally inserted central catheters: development of a hospital-based program. Journal of Intravenous Nursing 1990;13:287–290.
10.BeVier, PA, Rice, CE. Initiating a pediatric peripherally inserted central catheter and midline catheter program. Journal of Intravenous Nursing 1994;17:201–205.
11.Tomford, JW, Hershey, CO, McLaren, CE, Porter, DK, Cohen, DI. Intravenous therapy team and peripheral venous catheter-associated complications: a prospective controlled study. Arch Intern Med 1984; 144:1191–1194.
12.Wenzel, RP, Wentzel, RP. The development of academic programs for quality assessment. Arch Intern Med 1991;151:653–654.
13.Fridkin, SK, Pear, SM, Williamson, TH, GaLgiani, JN, Jarvis, WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996;17:150–158.
14.Robert, J, Fridkin, SK, Blumberg, HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000;21:12–17.
15.Vicca, AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999;43:109–113.
16.Pearson, ML. Guideline for prevention of intravascular device-related infections: Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996;24:262–277.
17.White, MC, Ragland, KE. Surveillance of intravenous catheter-related infections among home care clients. Am J Infect Control 1994;22:231–235.
18.Lorenzen, AN, Itkin, DJ. Surveillance of infection in home care. Am J Infect Control 1992;20:326–329.
19.White, MC. Infections and infection risks in home care settings. Infect Control Hosp Epidemiol 1992;13:535–539.
20.Pittet, D, Tarana, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients', excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
21.Raad, II, Baba, M, Bodey, GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995;20:593–597.
22.Widmer, AF, Nettleman, M, Flint, K, Wenzel, RP. The clinical impact of culturing central venous catheters: a prospective study. Arch Intern Med 1992;152:1299–1302.
23.Larson, EL, Rackoff, WR, Weiman, M, et al. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251–269.
24.Boyce, JM, Farr, BM, Jarvis, WR, et al. Guideline for hand hygiene in the healthcare setting. Am J Infect Control 2002. In press.
25.Bischoff, WE, Reynolds, TM, Sessler, CN, Edmond, MB, Wenzel, RP. Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med 2000;160:1017–1021.
26.Pittet, D, Dharan, S, Touveneau, S, Sauvan, V, Perneger, TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999;159:821–826.
27.Simmons, B, Bryant, J, Neiman, K, Spencer, L, Arheart, K. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol 1990;11:589–594.
28.Boyce, JM, Kelliher, S, Vallande, N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol 2000;21:442–448.
29.Mermel, LA, McCormick, RD, Springman, SR, Maki, DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular sub-typing. Am J Med 1991;91:197S–205S.
30.Raad, II, Hohn, DC, Gilbreath, BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231–238.
31.Capdevila, JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis 1998;2:230–236.
32.Abi-Said, D, Raad, I, Umphrey, J, et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 1999; 20:101–105.
33.Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;24:377–382.
34.Povoski, SP. A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients. Ann Surg Oncol 2000;7:496–502.
35.Arrighi, DA, Farnell, MB, Mucha, P Jr, Iistrup, DM, Anderson, DL. Prospective, randomized trial of rapid venous access for patients in hypovolemic shock. Ann Emerg Med 1989;18:927–930.
36.Ahmed, Z, Mohyuddin, Z. Complications associated with different insertion techniques for Hickman catheters. Postgrad Med J 1998;74:104–107.
37.Maki, DG, Ringer, M, Alvarado, CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339–343.
38.Garland, JS, Buck, RK, Maloney, Ret al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995;14:510–516.
39.Little, JR, Murray, PR, Traynor, PS, Spitznagel, E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med 1999;107:119–125.
40.Mimoz, O, Pieroni, L, Lawrence, C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996;24:1818–1823.
41.Maki, DG, McCormack, KN. Defatting catheter insertion sites in total parenteral nutrition is of no value as an infection control measure: controlled clinical trial. Am J Med 1987;83:833–840.
42.Maki, DG, Stolz, SS, Wheeler, S, Mermel, LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994;22:1729–1737.
43.Bijma, R, Girbes, AR, Kleijer, DJ, Zwaveling, JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1999;20:618–620.
44.Rasero, L, Degl'Innocenti, M, Mocali, M, et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. Haematologica 2000;85:275–279.
45.Madeo, M, Martin, CR, Turner, C, Kirkby, V, Thompson, DR. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Critical Care Nursing 1998;14:187–191.
46.Zakrzewska-Bode, A, Muytiens, HL, Liem, KD, Hoogkamp-Korstanje, JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995;31:189–193.
47.Flowers, RH, Schwenzer, KJ, Kopel, RF, Fisch, MJ, Tucker, SI, Farr, BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized, controlled trial. JAMA 1989:261:878–883.
48.Robbins, J, Cromwell, P, Korones, DN. Swimming and central venous catheter-related infections in the child with cancer. J Pediatr Oncol Nurs 1999;16:51–56.
49.Howell, PB, Walters, PE, Donowitz, GR, Farr, BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995;75:1367–1375.
50.Goetz, AM, Wagener, MM, Miller, JM, Muder, RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998;19:842–845.
51.Trottier, SJ, Veremakis, C, O'Brien, J, Auer, AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med 1995;23:52–59.
52.Goetz, AM, Miller, J, Wagener, MM, Muder, RR. Complications related to intravenous midline catheter usage: a 2-year study. Journal of Intravenous Nursing 1998;21:76–80.
53.Martin, C, Viviand, X, Saux, P, Gouin, F. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med 1999;27:2626–2629.
54.Robinson, JF, Robinson, WA, Cohn, AGarg, K, Armstrong, JD 2nd. Perforation of the great vessels during central venous line placement. Arch Intern Med 1995;155:1225–1228.
55.Lederle, FA, Parenti, CM, Berskow, LC, Ellingson, KJ. The idle intravenous catheter. Ann Intern Med 1992;116:737–738.
56.Parenti, CM, Lederle, FA, Impola, CL, Peterson, LR. Reduction of unnecessary intravenous catheter use: internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994;154:1829–1832.
57.Cook, D, Randolph, A, Kernerman, P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997;25:1417–1424.
58.Cobb, DK, High, KP, Sawyer, RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327:1062–1068.
59.Thomas, F, Burke, JP, Parker, J, et al. The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med 1983;11:807–812.
60.Lai, KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J Infect Control 1998;26:66–70.
61.Garland, JS, Dunne, WM Jr, Havens, P, et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992;89:1145–1150.
62.Garland, JS, Nelson, DB, Cheah, TE, Hennes, HH, Johnson, TM. Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis J 1987;6:918–921.
63.Nelson, DB, Garland, JS. The natural history of Teflon catheter-associated phlebitis in children. Am J Dis Child 1987;141:1090–1092.
64.Shimandle, RB, Johnson, D, Baker, M, Stotland, N, Karrison, T, Arnow, PM. Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol 1999;20:736–740.
65.O'Grady, NP, Barie, PS, Bartlett, J, et al. Practice parameters for evaluating new fever in critically ill adult patients: Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Diseases Society of America. Crit Care Med 1998;26:392–408.
66.Mermel, LA, Farr, BM, Sherertz, RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249–1272.
67.Sitges-Serra, ALinares, J, Perez, JL, Jaurrieta, E, Lorente, L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985; 9:322–325.
68.Josephson, A, Gombert, ME, Sierra, MF, Karanfil, LV, Tansino, GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985;6:367–370.
69.Maki, DG, Botticelli, JT, LeRoy, ML, Thielke, TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA 1987;258:1777–1781.
70.Snydman, DR, Donnelly-Reidy, M, Perry, LK, Martin, WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987;8:113–116.
71.Melly, MA, Meng, HC, Schaffner, W. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg 1975;110:1479–1481.
72.Mershon, J, Nogami, W, Williams, JM, Yoder, C, Eitzen, HE, Lemons, JA. Bacterial/fungal growth in a combined parenteral nutrition solution. JPEN J Parenter Enteral Nutr 1986;10:498–502.
73.Gilbert, M, Gallagher, SC, Eads, M, Elmore, MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. JPEN J Parenter Enteral Nutr 1986;10:494–497.
74.Maki, DG, Martin, WT. Nationwide epidemic of septicemia caused by contaminated infusion products: IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 1975;131:267–272.
75.Didier, ME, Fischer, S, Maki, DG. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature. JPEN J Parenter Enteral Nutr 1998;22:291–296.
76.Bennett, SN, McNeil, MM, Bland, LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995;333:147–154.
77.Arduino, MJ, Bland, LA, Danzig, LE, McAllister, SK, Aguero, SM. Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control 1997;25:377–380.
78.Brown, JD, Moss, HA, Elliott, TS. The potential for catheter microbial contamination from a needleless connector. J Hosp Infect 1997;36:181–189.
79.Cookson, ST, Ihrig, M, O'Mara, EM, et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998;19:23–27.
80.Luebke, MA, Arduino, MJ, Duda, DL, et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998;26:437–441.
81.McDonald, LC, Banerjee, SN, Jarvis, WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol 1998;19:772–777.
82.Mendelson, MH, Short, LJ, Schechter, CB, et al. Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol 1998;19:401–406.
83.Seymour, VM, Dhallu, TS, Moss, HATebbs, SE, Elliot, TS. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect 2000;45:165–168.
84.Do, AN, Ray, BJ, Banerjee, SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999;179:442–448.
85.Crocker, KS, Noga, R, Filibeck, DJ, Krey, SH, Markovic, M, Steffee, WP. Microbial growth comparisons of five commercial parenteral lipid emulsions. JPEN J Parenter Enteral Nutr 1984;8:391–395.
86.Jarvis, WR, Highsmith, AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol 1984;19:17–20.
87.Roth, VR, Arduino, MJ, Nobiletti, J, et al. Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion 2000;40:931–935.
88.Blajchman, MA. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol 2000;102:183–193.
89.Barrett, BB, Andersen, JW, Anderson, KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993;33:228–233.
90.Wagner, SJ, Friedman, LI, Dodd, RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7:290–302.
91.Plott, RT, Wagner, RF Jr, Tyring, SK. Iatrogenic contamination of multi-dose vials in simulated use: a reassessment of current patient injection technique. Arch Dermatol 1990;126:1441–1444.
92.Salzman, MB, Isenberg, HD, Rubin, LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993;31:475–479.
93.ASHP Council on Professional Affairs. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm 2000;57:1150–1169.
94.Herruzo-Cabrera, R, Garcia-Caballero, J, Vera-Cortes, ML, et al. Growth of microorganisms in parenteral nutrient solutions. Am J Hosp Pharm 1984;41:1178–1180.
95.Green, KA, Mustachi, B, Schoer, K, Moro, D, Blend, R, McGeer, A. Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients. AJR Am J Roentgenol 1995;165:669–671.
96.Arlington, ME, Gabbert, KC, Mazgaj, FW, Wolf, MT. Multidose vial contamination in anesthesia. AANA J 1990;58:462–466.
97.Maddox, RR, John, JF Jr, Brown, LL, Smith, CE. Effect of inline filtration on postinfusion phlebitis. Clin Pharm 1983;2:58–61.
98.Falchuk, KH, Peterson, L, McNeil, BJ. Microparticulate-induced phlebitis: its prevention by in-line filtration. N Engl J Med 1985;312:78–82.
99.Cohran, J, Larson, E, Roach, H, Blane, C, Pierce, P. Effect of intravascular surveillance and education program on rates of nosocomial bloodstream infections. Heart Lung 1996;25:161–164.
100.McKee, R, Dunsmuir, R, Whitby, M, Garden, OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985;6:419–425.
101.Ranson, MR, Oppenheim, BA, Jackson, A, Kamthan, AG, Scarffe, JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15:95–102.
102.Miller, MA, Dascal, A, Portnoy, J, Mendelson, J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811–813.
103.Netto dos Santos, KR, de Souza Fonseca, L, Gontijo Filho, PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996;17:813–816.
104.Band, JD, Maki, DG. Steel needles used for intravenous therapy: morbidity in patients with hematologic malignancy. Arch Intern Med 1980; 140:31–34.
105.Tully, JL, Friedland, GH, Baldini, LM, Goldmann, DA. Complications of intravenous therapy with steel needles and Teflon catheters: a comparative study. Am J Med 1981;70:702–706.
106.Ryder, MA. Peripheral access options. Surg Oncol Clin N Am 1995; 4:395–427.
107.Maki, DG, Goldman, DA, Rhame, FS. Infection control in intravenous therapy. Ann Intern Med 1973;79:867–887.
108.Maki, DG, Ringer, M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med 1991;114:845–854.
109.Tager, IB, Ginsberg, MB, Ellis, SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983;118:839–851.
110.Mermel, LA, Parenteau, S, Tow, SM. The risk of midline catheterization in hospitalized patients: a prospective study. Ann Intern Med 1995; 123:841–844.
111.Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report: data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26:522–533.
112.Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520–532.
113.Banerjee, SN, Emori, TG, Culver, DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989: National Nosocomial Infections Surveillance System. Am J Med 1991; 91:86S–89S.
114.Horan, TC, Emori, TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997;25:112–116.
115.Khuri-Bulos, NA, Shennak, M, Agabi, S, et al. Nosocomial infections in the intensive care units at a university hospital in a developing country: comparison with National Nosocomial Infections Surveillance intensive care unit rates. Am J Infect Control 1999;27:547–552.
116.Pittet, D, Wenzel, RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177–1184.
117.Centers for Disease Control and Prevention. Monitoring hospital-acquired infections to promote patient safety: United States, 1990-1999. MMWR 2000;49:149–153.
118.Joint Commission on the Accreditation of Healthcare Organizations. Accreditation Manual for Hospitals. Chicago: Joint Commission on the Accreditation of Healthcare Organizations; 1994:121–140.
119.Clark-Christoff, N, Watters, VA, Sparks, W, Snyder, P, Grant, JP. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. JPEN J Parenter Enteral Nutr 1992;16:403–407.
120.Early, TF, Gregory, RT, Wheeler, JR, Snyder, SO Jr, Gayle, RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J 1990;83:34–36.
121.Hilton, E, Haslett, TM, Borenstein, MT, Tucci, V, Isenberg, HD, Singer, C. Central catheter infections: single- versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters. Am J Med 1988;84:667–672.
122.Yeung, C, May, J, Hughes, R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol 1988;9:154–158.
123.Raad, I, Darouiche, R, Dupuis, J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997;127:267–274.
124.Veenstra, DL, Saint, S, Saha, S, Lumley, T, Sullivan, SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281:261–267.
125.Maki, DG, Stolz, SM, Wheeler, S, Mermel, LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257–266.
126.Veenstra, DL, Saint, S, Sullivan, SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999;282:554–560.
127.Darouiche, RO, Raad, II, Heard, SO, et al. A comparison of two antimicrobial-impregnated central venous catheters: Catheter Study Group. N Engl J Med 1999;340:1–8.
128.Collin, GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999;115:1632–1640.
129.Groeger, JS, Lucas, AB, Thaler, HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168–1174.
130.Pegues, D, Axelrod, P, McClarren, C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992;49:156–162.
131.Foundation, NK III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001;37:S137–S181.
132.Moss, AH, Vasilakis, C, Holley, JL, Foulks, CJ, Pillai, K, McDowell, DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990;16:211–215.
132.Hoen, B, Paul-Dauphin, A, Hestin, D, Kessler, M. EPIBACDIAL: a multi-center prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9:869–876.
134.Levin, A, Mason, AJ, Jindal, KK, Fong, IW, Goldstein, MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991;40:934–938.
135.Maki, DG, Band, JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981;70:739–744.
136.Merrer, J, De Jonghe, B, Golliot, F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286:700–707.
137.Venkataraman, ST, Thompson, AE, Orr, RA. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr (Phila) 1997; 36:311–319.
138.Stenzel, JP, Green, TP, Fuhrman, BP, Carlson, PE, Marchessault, RP. Percutaneous femoral venous catheterizations: a prospective study of complications. J Pediatr 1989;114:411–415.
139.Goldstein, AM, Weber, JM, Sheridan, RL. Femoral venous access is safe in burned children: an analysis of 224 catheters. J Pediatr 1997; 130:442–446.
140.Schillinger, F, Schillinger, D, Montagnac, R, Milcent, T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991;6:722–724.
141.Cimochowski, GE, Worley, E, Rutherford, WE, Sartain, J, Blondin, J, Harter, H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990;54:154–161.
142.Barrett, N, Spencer, S, McIvor, J, Brown, EA. Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant 1988;3:423–425.
143.Trerotola, SO, Kuhn-Fulton, J, Johnson, MS, Shah, H, Ambrosius, WT, Kneebone, PH. Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology 2000;217:89–93.
144.Macdonald, S, Watt, AJ, McNally, D, Edwards, RD, Moss, JG. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches. J Vase Interv Radiol 2000;11:225–231.
145.Cohen, Y, Fosse, JP, Karoubi, P, et al. The “hands-off” catheter and the prevention of systemic infections associated with pulmonary artery catheter: a prospective study. Am J Respir Crit Care Med 1998;157:284–287.
146.Eyer, S, Brummitt, C, Crossley, K, Siegel, R, Cerra, F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990;18:1073–1079.
147.Widmer, AF. Management of catheter-related bacteremia and fungemia in patients on total parenteral nutrition. Nutrition 1997;13:18S–25S.
148.Powell, C, Kudsk, KA, Kulich, PA, Mandelbaum, JA, Fabri, PJ. Effect of frequent guidewire changes on triple-lumen catheter sepsis. JPEN J Parenter Enteral Nutr 1988;12:462–464.
149.Snydman, DR, Murray, SA, Kornfeld, SJ, Majka, JA, Ellis, CA. Total parenteral nutrition-related infections: prospective epidemiologic study using semiquantitative methods. Am J Med 1982;73:695–699.
150.Henrickson, KJ, Axtell, RA, Hoover, SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000;18:1269–1278.
151.Carratala, J, Niubo, J, Fernandez-Sevilla, A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999;43:2200–2204.
152.Easom, A. Prophylactic antibiotic lock therapy for hemodialysis catheters. Nephrol Nurs J 2000;27:75.
153.Vercaigne, LM, Sitar, DS, Penner, SB, Bernstein, K, Wang, GQ, Burczynski, FJ. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000;20:394–399.
154.Maki, DG, Ringer, M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987;258:2396–2403.
155.Garland, JS, Alex, CP, Mueller, CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431–1436.
156.Rao, SP, Oreopoulos, DG. Unusual complications of a polyurethane PD catheter. Pent Dial Int 1997;17:410–412.
157.Riu, S, Ruiz, CG, Martinez-Vea, A, Peralta, C, Oliver, JA. Spontaneous rupture of polyurethane peritoneal catheter: a possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998;13:1870–1871.
158.Donowitz, LG, Marsik, FJ, Hoyt, JW, Wenzel, RP. Serratia marcescens bacteremia from contaminated pressure transducers. JAMA 1979;242:1749–1751.
159.Luskin, RL, Weinstein, RA, Nathan, C, Chamberlin, WH, Kabins, SA. Extended use of disposable pressure transducers: a bacteriologie evaluation. JAMA 1986;255:916–920.
160.Maki, DG, Hassemer, CA. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring. Am J Med 1981;70:733–738.
161.Mermel, LAMaki, DG. Epidemic bloodstream infections from hemodynamic pressure monitoring: signs of the times. Infect Control Hosp Epidemiol 1989;10:47–53.
162.Tenold, R, Priano, L, Kim, K, Rourke, B, Marrone, T. Infection potential of nondisposable pressure transducers prepared prior to use. Crit Care Med 1987;15:582–583.
163.Raad, I, Umphrey, J, Khan, A, Truett, LJ, Bodey, GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 1993;23:17–26.
164.Leroy, O, Billiau, V, Beuscart, C, et al. Nosocomial infections associated with long-term radial artery cannulation. Intensive Care Medicine 1989; 15:241–246.
165.Fisher, MC, Long, SS, Roberts, EM, Dunn, JM, Balsara, RK. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA 1981;246:1571–1574.
166.Stamm, WE, Colella, JJ, Anderson, RL, Dixon, RE. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med 1975;292:1099–1102.
167.Weinstein, RA, Emori, TG, Anderson, RL, Stamm, WE. Pressure transducers as a source of bacteremia after open heart surgery: report of an outbreak and guidelines for prevention. Chest 1976;69:338–344.
168.Shinozaki, T, Deane, RS, Mazuzan, JE Jr, Hamel, AJ, Hazelton, D. Bacterial contamination of arterial lines: a prospective study. JAMA 1983;249:223–225.
169.Solomon, SL, Alexander, H, Eley, JW, et al. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis 1986;5:680–655.
170.Weems, JJ Jr, Chamberland, ME, Ward, J, Willy, M, Padhye, AA, Solomon, SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987; 25:1029–1032.
171.Beck-Sague, CM, Jarvis, WR, Brook, JH, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol 1990;132:723–733.
172.Villarino, ME, Jarvis, WR, O'Hara, C, Bresnahan, J, Clark, N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989;27:2433–2436.
173.Boo, NY, Wong, NC, Zulkifli, SS, Lye, MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999;35:460–465.
174.Krauss, AN, Albert, RF, Kannan, MM. Contamination of umbilical catheters in the newborn infant. J Pediatr 1970;77:965–969.
175.Landers, S, Moise, AA, Fraley, JK, Smith, EO, Baker, CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child 1991;145:675–680.
176.Cronin, WA, Germanson, TP, Donowitz, LG. Intravascular catheter colonization and related bloodstream infection in critically ill neonates. Infect Control Hosp Epidemiol 1990;11:301–308.
177.Miller, KL, Coen, PE, White, WJ, Hurst, WJ, Achey, BE, Lang, CM. Effectiveness of skin absorption of tincture of I in blocking radioiodine from the human thyroid gland. Health Phys 1989;56:911–914.
178.Ankola, PA, Atakent, YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol 1993;10:229–232.
179.Horgan, MJ, Bartoletti, A, Polansky, S, Peters, JC, Manning, TJ, Lamont, BM. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr 1987;111:774–778.
180.David, RJ, Merten, DF, Anderson, JC, Gross, S. Prevention of umbilical artery catheter clots with heparinized infusates. Dev Pharmacol Ther 1981;2:117–126.
181.Fletcher, MA, Brown, DR, Landers, S, Seguin, J. Umbilical arterial catheter use: report of an audit conducted by the Study Group for Complications of Perinatal Care. Am J Perinatol 1994;11:94–99.
182.Seguin, J, Fletcher, MA, Landers, S, Brown, D, Macpherson, T. Umbilical venous catheterizations: audit by the Study Group for Complications of Perinatal Care. Am J Perinatol 1994;11:67–70.
183.Loisel, DB, Smith, MM, MacDonald, MG, Martin, GR. Intravenous access in newborn infants: impact of extended umbilical venous catheter use on requirement for peripheral venous lines. J Perinatol 1996;16:461–466.